$26.12
3M Ago | 1M Ago | Current | |
Buy | 11 | 12 | 12 |
Outperform | 5 | 5 | 5 |
Hold | 3 | 3 | 3 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Bridgebio Pharma Inc (BBIO) is $48, offered by 20 analysts offering 12-month price forecasts.
Bridgebio Pharma Inc (BBIO) has a maximum of 0.84 upside potential, based on 20 analysts offering 12-month price forecasts.
Based on 20 analysts tracking and researching Bridgebio Pharma Inc (BBIO), 85% have a buy recommendation. Remaining 15% have either sell or hold recommendations.
The latest share price of Bridgebio Pharma Inc (BBIO) is $26.12 as of 13/11/2024.
17 of total 20 analysts offering stock ratings for Bridgebio Pharma Inc BBIO have recommended buy rating.